Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 6/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.40 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5464969 | 1.00 | PTGS2 (0.45) | PTGS2ALOX5CA2CA1HSP90AA1 | |
| SCHEMBL5463108 | 0.81 | CA2 (0.61) | PTGS2CA2CA1ALDH1A1SMN1; SMN2 | |
| SCHEMBL5463105 | 0.81 | CA2 (0.61) | PTGS2CA2CA1ALDH1A1SMN1; SMN2 | |
| SCHEMBL28121198 | 0.81 | ALOX5 (0.47) | PTGS2ALOX5CA2CA1HSP90AA1 | |
| SCHEMBL689068 | 0.80 | PTGS2 (0.50) | PTGS2ALOX5CA2CA1HSP90AA1 | |
| SCHEMBL27958938 | 0.80 | ALOX5 (0.47) | PTGS2ALOX5CA2CA1HSP90AA1 | |
| SCHEMBL1615105 | 0.80 | PTGS2 (0.50) | PTGS2ALOX5CA2CA1HSP90AA1 | |
| SCHEMBL187267 | 0.79 | ALOX5 (0.49) | PTGS2ALOX5CA2CA1HSP90AA1 | |
| SCHEMBL29467330 | 0.79 | ALOX5 (0.49) | PTGS2ALOX5CA2CA1HSP90AA1 | |
| SCHEMBL17750808 | 0.79 | ALOX5 (0.46) | PTGS2ALOX5CA2CA1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12129320-B2 | Materials for reducing acids from liquid phases | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2024-10-29 | — | — | US | disclosed |
| US-20240052080-A1 | MATERIALS FOR REDUCING ACIDS FROM LIQUID PHASES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2024-02-15 | — | — | US | disclosed |
| US-20220056181-A1 | MATERIALS FOR REDUCING ACIDS FROM LIQUID PHASES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2022-02-24 | — | — | US | disclosed |
| US-20210395923-A1 | PHOTOPOLYMERIZABLE COMPOSITIONS FOR SOLVENTLESS FIBER SPINNING | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2021-12-23 | — | — | US | disclosed |
| US-20190211477-A1 | PHOTOPOLYMERIZABLE COMPOSITIONS FOR SOLVENTLESS FIBER SPINNING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2019-07-11 | — | — | US | disclosed |
| US-10221503-B2 | Photopolymerizable compositions for solventless fiber spinning | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2019-03-05 | — | — | US | disclosed |
| US-9162191-B2 | Imidazole-containing polymer membranes and methods of use | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2015-10-20 | — | — | US | disclosed |
| US-20140130416-A1 | Imidazole-Containing Polymer Membranes and Methods of Use | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2014-05-15 | — | — | US | disclosed |
| US-20140039150-A1 | PHOTOPOLYMERIZABLE COMPOSITIONS FOR SOLVENTLESS FIBER SPINNING | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-02-06 | — | — | US | disclosed |
| WO-2012138960-A1 | PHOTOPOLYMERIZABLE COMPOSITIONS FOR SOLVENTLESS FIBER SPINNING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20070043205-A1 | Radiation curable thiol-ene composition | DSM IP ASSETS B.V. (NL) | 2007-02-22 | — | — | US | disclosed |
| EP-1477511-A1 | Radiation curable thiol-ene composition | DSM IP Assets B.V. (NL) | 2004-11-17 | — | — | EP | disclosed |
| EP-0810251-A2 | Storage-stable one-component air activated formulations of polythiol and polyene employing iron compound | LOCTITE (IRELAND) LIMITED (IE) | 1997-12-03 | — | — | EP | disclosed |
| US-5558937-A | NORBORNENE-THIOL-OXYBUTYLENE POLYMER | LOCTITE CORPORATION (US) | 1996-09-24 | — | — | US | disclosed |
| US-5459175-A | A polythiol compound and a norbornene functional polytetra-methylene oxide | LOCTITE CORPORATION (US) | 1995-10-17 | — | — | US | disclosed |
| WO-1995000869-A1 | OPTICAL FIBER PRIMARY COATINGS AND FIBERS COATED THEREWITH | LOCTITE CORPORATION (US) | 1995-01-05 | — | — | WO | disclosed |
| WO-1995000557-A1 | THIOL-ENE COMPOSITIONS WITH IMPROVED CURE SPEED RETENTION | LOCTITE CORPORATION (US) | 1995-01-05 | — | — | WO | disclosed |
| US-5371181-A | Contacting p(olythiol with ammphoteric treating agent, mixing with polyene and shelf life stabilizer comprosing hydroxyl-amine salt | LOCTITE CORPORATION (US) | 1994-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240052080-A1 | MATERIALS FOR REDUCING ACIDS FROM LIQUID PHASES | TTPA, EMD, PPIP5K2 | PTGS2 100/4885ALOX5 495/4885CA2 914/4885 |
| US-12129320-B2 | Materials for reducing acids from liquid phases | TTPA, EMD, PPIP5K2 | PTGS2 100/4885ALOX5 495/4885CA2 914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.